<atl>Safety and immunogenicity of a iKlebsiella pneumoniae/i tetravalent bioconjugate vaccine (Kleb4V) administered to healthy adults: A first time in human phase I/II randomised and controlled study</atl>

Journal:
Journal of Infectious Diseases
Published:
DOI:
10.1093/infdis/jiaf600
Affiliations:
3
Authors:
8
Go to article
Institutions Authors Share
UCL, United Kingdom (UK)
4.000000
 0.50
LimmaTech Biologics AG, Switzerland
3.000000
 0.38
Nuvisan ICB GmbH, Germany
1.000000
 0.13
Interested in Clinical Sciences?